NLRP3 and inflammatory bowel disease: Besides, in inflammatory bowel disease, levels of IL-1β in MLNs increase significantly, and inhibition of NLRP3/IL-1β signal axis is thought to improve the symptoms of SAE (Sui et al., 2016).